Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
90
PharmaCompass offers a list of Bismuth Potassium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bismuth Potassium Citrate manufacturer or Bismuth Potassium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bismuth Potassium Citrate manufacturer or Bismuth Potassium Citrate supplier.
PharmaCompass also assists you with knowing the Bismuth Potassium Citrate API Price utilized in the formulation of products. Bismuth Potassium Citrate API Price is not always fixed or binding as the Bismuth Potassium Citrate Price is obtained through a variety of data sources. The Bismuth Potassium Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Calloidal bismuth subcitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calloidal bismuth subcitrate, including repackagers and relabelers. The FDA regulates Calloidal bismuth subcitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calloidal bismuth subcitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calloidal bismuth subcitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calloidal bismuth subcitrate supplier is an individual or a company that provides Calloidal bismuth subcitrate active pharmaceutical ingredient (API) or Calloidal bismuth subcitrate finished formulations upon request. The Calloidal bismuth subcitrate suppliers may include Calloidal bismuth subcitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Calloidal bismuth subcitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calloidal bismuth subcitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Calloidal bismuth subcitrate active pharmaceutical ingredient (API) in detail. Different forms of Calloidal bismuth subcitrate DMFs exist exist since differing nations have different regulations, such as Calloidal bismuth subcitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calloidal bismuth subcitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Calloidal bismuth subcitrate USDMF includes data on Calloidal bismuth subcitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calloidal bismuth subcitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calloidal bismuth subcitrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Calloidal bismuth subcitrate Drug Master File in Korea (Calloidal bismuth subcitrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Calloidal bismuth subcitrate. The MFDS reviews the Calloidal bismuth subcitrate KDMF as part of the drug registration process and uses the information provided in the Calloidal bismuth subcitrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Calloidal bismuth subcitrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Calloidal bismuth subcitrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Calloidal bismuth subcitrate suppliers with KDMF on PharmaCompass.
Calloidal bismuth subcitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calloidal bismuth subcitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calloidal bismuth subcitrate GMP manufacturer or Calloidal bismuth subcitrate GMP API supplier for your needs.
A Calloidal bismuth subcitrate CoA (Certificate of Analysis) is a formal document that attests to Calloidal bismuth subcitrate's compliance with Calloidal bismuth subcitrate specifications and serves as a tool for batch-level quality control.
Calloidal bismuth subcitrate CoA mostly includes findings from lab analyses of a specific batch. For each Calloidal bismuth subcitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calloidal bismuth subcitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calloidal bismuth subcitrate EP), Calloidal bismuth subcitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calloidal bismuth subcitrate USP).
